Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan flag Jordan · Delayed Price · Currency is JOD
1.590
0.00 (0.00%)
At close: May 10, 2026

ASE:PHIL Balance Sheet

Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.771.831.651.41.51.66
Cash & Short-Term Investments
1.771.831.651.41.51.66
Cash Growth
-0.58%10.53%18.11%-6.64%-9.82%3.74%
Accounts Receivable
6.766.536.386.456.246.7
Other Receivables
-0.040.05-0.070.07
Receivables
6.766.566.436.456.316.78
Inventory
2.512.271.91.891.421.66
Prepaid Expenses
-0.360.160.180.140.11
Other Current Assets
0.60.120.10.190.030.03
Total Current Assets
11.6311.1310.2410.129.3910.24
Property, Plant & Equipment
2.812.832.882.062.292.39
Other Intangible Assets
3.18----2.44
Long-Term Deferred Charges
-3.263.553.854.14-
Total Assets
17.6317.2216.6716.0315.8215.07
Accounts Payable
1.261.331.231.351.131.09
Accrued Expenses
00.280.240.240.280.22
Short-Term Debt
0.890.510.671.491.831.45
Current Portion of Long-Term Debt
0.720.540.48---
Current Income Taxes Payable
0.190.270.140.130.10.08
Other Current Liabilities
0.610.060.040.060.090.11
Total Current Liabilities
3.672.992.793.283.442.94
Long-Term Debt
0.710.710.84---
Total Liabilities
4.383.73.633.283.442.94
Common Stock
7.57.57.57.57.57.5
Retained Earnings
5.756.025.545.244.894.63
Shareholders' Equity
13.2513.5213.0412.7412.3912.13
Total Liabilities & Equity
17.6317.2216.6716.0315.8215.07
Total Debt
2.311.761.991.491.831.45
Net Cash (Debt)
-0.540.07-0.33-0.09-0.330.21
Net Cash Per Share
-0.070.01-0.04-0.01-0.040.03
Filing Date Shares Outstanding
7.57.57.57.57.57.5
Total Common Shares Outstanding
7.57.57.57.57.57.5
Working Capital
7.968.147.456.835.967.3
Book Value Per Share
1.771.801.741.701.651.62
Tangible Book Value
10.0613.5213.0412.7412.399.69
Tangible Book Value Per Share
1.341.801.741.701.651.29
Land
-1.051.050.120.120.12
Buildings
-1.651.641.61.591.59
Machinery
-3.833.823.733.673.58
Source: S&P Global Market Intelligence. Standard template. Financial Sources.